Assessment of the Forward Contamination Risk of Mars by Clean Room Isolates from Space-Craft Assembly Facilities through Aeolian Transport - a Model Study.

The increasing number of missions to Mars also increases the risk of forward contamination. Consequently there is a need for effective protocols to ensure efficient protection of the Martian environment against terrestrial microbiota. Despite the fact of constructing sophisticated clean rooms for spacecraft assembly a 100 % avoidance of contamination appears to be impossible. Recent surveys of these facilities have identified a significant number of microbes belonging to a variety of taxonomic groups that survive the harsh conditions of clean rooms. These microbes may have a strong contamination potential, which needs to be investigate to apply efficient decontamination treatments. In this study we propose a series of tests to evaluate the potential of clean room contaminants to survive the different steps involved in forward contamination. We used Staphylococcus xylosus as model organism to illustrate the different types of stress that potential contaminants will be subjected to on their way from the spacecraft onto the surface of Mars. Staphylococcus xylosus is associated with human skin and commonly found in clean rooms and could therefore contaminate the spacecraft as a result of human activity during the assembling process. The path the cell will take from the surface of the spacecraft onto the surface of Mars was split into steps representing different stresses that include desiccation, freezing, aeolian transport in a Martian-like atmosphere at Martian atmospheric pressure, and UV radiation climate. We assessed the surviving fraction of the cellular population after each step by determining the integrated metabolic activity of the survivor population by measuring their oxygen consumption rate. The largest fraction of the starting culture (around 70 %) was killed during desiccation, while freezing, Martian vacuum and short-term UV radiation only had a minor additional effect on the survivability of Staphylococcus xylosus. The study also included a simulation of atmospheric transport on Martian dust, which did not significantly alter the metabolic potential of the cells. The high survival potential of skin microbes, which are not among the most robust isolates, clearly underlines the necessity for efficient decontamination protocols and of adequate planetary protection measures. Thus we propose a series of tests to be included into the description of isolates from spacecraft assembly clean rooms in order to assess the forward contamination potential of the specific isolate and to categorize the risk level according to the organisms survival potential. We are aware that the tests that we propose do not exhaust the types of challenges that the microbes would meet on their way and therefore the series of tests is open to being extended.

Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.

BACKGROUND & METHODS: Within the last decade Virus-Like Particles (VLPs) have increasingly received attention from scientists for their use as a carrier of (peptide) molecules or as scaffold to present epitopes for use in subunit vaccines. To test the feasibility of Cowpea chlorotic mottle virus (CCMV) particles as a scaffold for epitope presentation and identify sites for epitope fusion or insertion that would not interfere with virus-like-particle formation, chimeric CCMV coat protein (CP) gene constructs were engineered, followed by expression in E. coli and assessment of VLP formation. Various constructs were made encoding a 6x-His-tag, or selected epitopes from Influenza A virus [IAV] (M2e, HA) or Foot and Mouth Disease Virus [FMDV] (VP1 and 2C). The epitopes were either inserted 1) in predicted exposed loop structures of the CCMV CP protein, 2) fused to the amino- (N) or carboxyl-terminal (C) ends, or 3) to a N-terminal 24 amino acid (aa) deletion mutant (N∆24-CP) of the CP protein. RESULTS: High levels of insoluble protein expression, relative to proteins from the entire cell lysate, were obtained for CCMV CP and all chimeric derivatives. A straightforward protocol was used that, without the use of purification columns, successfully enabled CCMV CP protein solubilization, reassembly and subsequent collection of CCMV CP VLPs. While insertions of His-tag or M2e (7-23 aa) into the predicted external loop structures did abolish VLP formation, high yields of VLPs were obtained with all fusions of His-tag or various epitopes (13- 27 aa) from IAV and FMDV at the N- or C-terminal ends of CCMV CP or N∆24-CP. VLPs derived from CCMV CP still encapsulated RNA, while those from CCMV CP-chimera containing a negatively charged N-terminal domain had lost this ability. The usefulness and rapid ease of exploitation of CCMV VLPs for the production of potential subunit vaccines was demonstrated with the synthesis of chimeric CCMV VLPs containing selected sequences from the GN and GC glycoproteins of the recently emerged Schmallenberg orthobunyavirus at both termini of the CP protein. CONCLUSIONS: CCMV VLPs can be successfully exploited as scaffold for epitope fusions up to 31 aa at the N- and C-terminus, and at a N-terminal 24 amino acid (aa) deletion mutant (N∆24-CP) of the CP protein.

H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO.

The recently discovered prokaryotic CRISPR/Cas defence system provides immunity against viral infections and plasmid conjugation. It has been demonstrated that in Escherichia coli transcription of the Cascade genes (casABCDE) and to some extent the CRISPR array is repressed by heat-stable nucleoid-structuring (H-NS) protein, a global transcriptional repressor. Here we elaborate on the control of the E. coli CRISPR/Cas system, and study the effect on CRISPR-based anti-viral immunity. Transformation of wild-type E. coli K12 with CRISPR spacers that are complementary to phage Lambda does not lead to detectable protection against Lambda infection. However, when an H-NS mutant of E. coli K12 is transformed with the same anti-Lambda CRISPR, this does result in reduced sensitivity to phage infection. In addition, it is demonstrated that LeuO, a LysR-type transcription factor, binds to two sites flanking the casA promoter and the H-NS nucleation site, resulting in derepression of casABCDE12 transcription. Overexpression of LeuO in E. coli K12 containing an anti-Lambda CRISPR leads to an enhanced protection against phage infection. This study demonstrates that in E. coli H-NS and LeuO are antagonistic regulators of CRISPR-based immunity.